fl/fl mice (low fat, 32±14; high fat, 219±58 pg/mL; P<0.05). In contrast, high fat-fed Agt aP2 mice did not exhibit elevated plasma angiotensin II concentrations (high fat, 18±7 pg/mL). Similarly, adipose tissue concentrations of angiotensin II were significantly decreased in low fat-and high fat-fed Agt aP2 mice compared with controls. In conclusion, adipocyte angiotensinogen deficiency prevented high fat-induced elevations in plasma angiotensin II concentrations and systolic blood pressure. These results suggest that adipose tissue serves as a major source of angiotensin II in the development of obesity hypertension. 
T he prevalence of hypertension has surged over the last 10 years consistent with an increasing incidence of obesity. 1 In men, a rise in body mass index is the primary contributor to the increased prevalence of hypertension. 1 Factors that consistently link obesity to hypertension include increased sodium reabsorption and activity of the sympathetic nervous system and the renin-angiotensin system (RAS). [2] [3] [4] The RAS is activated in human and experimental obesity. [5] [6] [7] [8] [9] [10] [11] Previous studies demonstrated activation of the systemic RAS in experimental models of diet-induced obesity. 5, 6, 12, 13 Obesityprone rats fed a moderately high-fat (HF) diet exhibited increased plasma angiotensin II (Ang II) concentrations and elevated systolic blood pressures (SBPs). 5 Administration of an angiotensin type 1 receptor antagonist to obese rats normalized blood pressure. 12 In humans, administration of inhibitors of the RAS is an effective therapy for the treatment of obesityrelated hypertension. 14 However, mechanisms for a stimulated RAS in the setting of obesity are not well defined.
Angiotensinogen (AGT) is the only known precursor to Ang II. Early studies demonstrated a high level of AGT gene expression in rat adipose tissue. 15, 16 Moreover, AGT gene expression increased when stem cells were differentiated to mature white adipocytes. 17, 18 In addition to AGT, adipocytes express multiple components of the RAS required for the synthesis of Ang II 19, 20 and release angiotensin peptides. 19, 21, 22 In mice with transgenic overexpression of AGT in adipocytes, plasma AGT concentrations increased and were associated with increased SBP. 23 Conversely, adipocyte-specific AGT deficiency reduced plasma AGT concentrations and SBP in male and female mice fed a standard diet. 24 These results suggest that adipocyte-derived AGT modulates the systemic RAS and blood pressure control.
Expression of AGT in adipose tissue has been reported to increase, 5, 6, [25] [26] [27] [28] decrease, 11, 29 or not change 30 in human or experimental obesity. Differences in AGT gene expression in obese adipose tissue may arise from the source of tissue, species, or whether subjects exhibit obesity-related disorders. When corrected for adipose tissue mass, secretion of AGT from adipose tissue correlated positively to body mass index and SBP in obese humans and in HF-fed mice. 30 Moreover,
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Abstract-Previous studies demonstrated that diet-induced obesity increased plasma angiotensin II concentrations and elevated systolic blood pressures in male mice. Adipocytes express angiotensinogen and secrete angiotensin peptides. We hypothesize that adipocyte-derived angiotensin II mediates obesity-induced increases in systolic blood pressure in male high fat-fed C57BL/6 mice. Systolic blood pressure was measured by radiotelemetry during week 16 of low-fat or highfat feeding in Agt fl/fl and adipocyte angiotensinogen-deficient mice (Agt
aP2
). Adipocyte angiotensinogen deficiency had no effect on diet-induced obesity. Basal 24-hour systolic blood pressure was not different in low fat-fed Agt fl/fl compared with Agt aP2 mice (124±3 versus 128±3 mm Hg, respectively). In Agt fl/fl mice, high-fat feeding significantly increased systolic blood pressure (24 hours; 134±2 mm Hg; P<0.05). In contrast, high fat-fed Agt aP2 mice did not exhibit an increase in systolic blood pressure (126±2 mm Hg). Plasma angiotensin II concentrations were increased by high-fat feeding in Agt hypertrophied adipocytes, as well as other inflammatory cell types in obese adipose tissue, express components of the RAS required for the conversion of AGT to Ang II. Therefore, an expanded adipose tissue mass may serve as a source of systemic Ang II with obesity. We hypothesized that adipocyte-derived AGT or Ang II contributes to activation of the systemic RAS and blood pressure control in HF-fed male mice. In this study, we quantified effects of adipocyte-specific AGT deficiency on the development of obesity, activation of the adipose and systemic RAS, and on obesity-induced increases in blood pressure.
Methods

Animals
C57BL/6 mice with loxP sites flanking exon 2 of the AGT gene (1672 bp including exon 2), as described previously, 24 were bred to transgenic male C57BL/6 mice expressing aP2-Cre recombinase. For all of the studies, Agt fl/fl littermate controls were used for comparison with mice with adipocyte AGT deficiency (Agt aP2 ). Diets, radiotelemetry monitoring of blood pressure, measurement of plasma and adipose parameters, gene expression, and statistical analyses are described in online-only Data Supplement. Carotid artery catheters and radiotelemeters were implanted into anesthetized (isoflurane) mice during week 15 of diet feeding. At study end point, mice were anesthetized with ketamine/xylazine (100/10 mg/kg, IP) for exsanguination and tissue harvest. All of the procedures involving animals were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the institutional animal care and use committee at the University of Kentucky.
Results
Adipocyte AGT Deficiency Had No Significant Effect on the Development of Diet-Induced Obesity
Genotyping demonstrated the presence of a 182-bp band in Agt aP2 mice ( Figure S1A ). AGT mRNA abundance was not significantly influenced by diet or genotype in liver or kidneys from Agt fl/fl compared with Agt aP2 mice ( Figure S1B and S1C). In white adipose tissue, AGT mRNA abundance was modestly but not significantly increased in HF-fed Agt fl/fl compared with low-fat (LF)-fed Agt fl/fl mice ( Figure S1D ). AGT mRNA abundance was significantly decreased in adipose tissue from Agt aP2 compared with Agt fl/fl mice ( Figure S1D ; P<0.05). In LF-fed mice, Agt aP2 mice had increased body weights compared with Agt fl/fl mice starting at week 5 ( Figure 1A ; P<0.05). With HF feeding, body weight increased in both genotypes compared with LF-fed mice ( Figure 1A ; P<0.05). In addition, fat mass increased significantly in HF-fed mice of each genotype compared with LF-fed mice ( Figure 1B ; P<0.05). However, body weight ( Figure 1A) , lean, and fat mass ( Figure 1C; 
Adipocyte AGT Deficiency Prevented Obesity-Induced Increases in SBP
In LF-fed mice, adipocyte AGT deficiency had no significant effect on SBP (Figure 2A ; 24-hour; Figure S3 ), diastolic blood pressures, pulse pressures, physical activity, or heart rate ( Table 1) . Moreover, both genotypes of LF-fed mice exhibited significantly lower SBP during the day compared with night cycle ( Figure S3 ; P<0.05). In HF-fed mice of both genotypes, heart rate increased significantly, whereas physical activity was significantly decreased (Table 1; Because plasma AGT concentrations were increased to a similar extent in HF-fed mice of each genotype ( Figure  3A ), but Ang II concentrations differed markedly between genotypes ( Figure 3B ), we quantified plasma renin activity (PRA; angiotensin I generated by endogenous renin and AGT) and plasma renin concentration (PRC; angiotensin I generated by endogenous renin in the presence of exogenous AGT). PRA was not significantly different in LF-or HF-fed mice of each genotype (Figure 4 ). When plasma from LF-fed mice of each genotype was incubated with exogenous AGT to quantify PRC, angiotensin I production increased markedly ( Figure 4) Figure  5B ). In contrast to adipose, liver Ang II concentrations were at the limits of detection (<0.1 pg/mg of tissue) and were not influenced by genotype or diet (data not shown). To define mechanisms for differences in Ang II concentrations between adipose and liver, we quantified mRNA abundance of the prorenin receptor and angiotensin-converting enzyme (ACE). Adipose tissue from HF-fed mice of each genotype expressed relatively greater mRNA abundance for the prorenin receptor and ACE compared with liver ( Figure  6A 
Discussion
In this study, we investigated the role of adipocyte-derived AGT and Ang II in the development of obesity hypertension. A major finding is that adipocyte-specific deficiency of AGT prevented obesity-induced increases in SBP. Notably, adipocyte AGT deficiency also prevented obesity-induced increases in plasma Ang II concentrations, suggesting that adipose tissue is a significant contributor to systemic Ang II and blood pressure control. In support, adipose tissue Ang II concentrations tended to increase when normalized to total fat mass of obese mice and were reduced in HF-fed adipocyte AGT-deficient mice. In addition, adipose tissue expressed components (eg, ACE, prorenin receptor, cathepsin D, and tonin) that convert AGT to Ang II, whereas liver had relatively lower abundance of these processing enzymes and undetectable levels of Ang II. These results indicate that adipose tissue becomes a primary source of systemic Ang II and contributes to obesityinduced increases in SBP. It is well accepted that the liver is the primary source of systemic AGT in rodents and humans. Whole body deficiency of AGT markedly decreased plasma AGT concentrations and blood pressure in mice. 31 By comparison, adipocyte AGT deficiency in mice fed a standard diet reduced plasma AGT concentrations and SBP by 25%. 24 In this study, Agt aP2 mice fed an LF diet did not exhibit significant reductions in plasma AGT concentrations and SBP and had slightly higher body weights compared with Agt fl/fl mice. These results suggest that differences in diet composition (LF versus standard mouse diet) 24 may have influenced the body weight and blood pressure phenotype of adipocyte AGT deficiency. Results from this study demonstrate that plasma AGT concentrations were increased by obesity and were not influenced in adipocyte AGT-deficient mice. Thus, elevated systemic AGT concentrations in obese mice were not adipocyte derived and presumably came from liver. Moreover, modest elevations in AGT mRNA abundance in adipose tissue from HF-fed control mice, as demonstrated in this and previous studies, 5,6 most likely did not contribute to increased plasma AGT concentrations in obese mice.
A surprising finding was that, despite elevations in plasma AGT concentrations in obese adipocyte AGTdeficient mice, plasma Ang II concentrations were markedly reduced. These results demonstrate dissociation of plasma AGT concentrations from plasma Ang II levels, suggesting that elevated plasma Ang II of obese Agt fl/fl mice was not derived from systemic AGT. In humans, although changes in systemic AGT concentrations can influence the systemic RAS, [32] [33] [34] the high plasma AGT concentration in relation to the Michaelis constant for renin 35 supports renin as the rate-limiting step in Ang II production. In contrast, previous investigators demonstrated that mice exhibit low PRA. 36 In this study, despite a significant increase in plasma AGT concentrations in obese mice, generation of angiotensin I from endogenous renin in plasma was not different between obese and lean mice. However, on addition of exogenous AGT, angiotensin I generation increased markedly, demonstrating that plasma AGT concentrations were rate limiting. However, obese mice could not effectively convert exogenous AGT to angiotensin I in plasma, suggesting obesity-induced alterations in renin. Mechanisms for obesity-induced reductions in active PRC are unclear. However, previous studies demonstrated that PRA was reduced in obese hypertensive but not normotensive women. 37 Moreover, regional adiposity may influence renin, because central obesity was associated with increased PRA, whereas patients with peripheral obesity did not exhibit changes in renin activity. 38 Interestingly, in HF-fed adipocyte AGT-deficient mice exhibiting low plasma Ang II concentrations, the total renin pool (including prorenin) increased in plasma. These results suggest that obese adipocyte AGT-deficient mice respond to low systemic Ang II concentrations to increase prorenin production. Further studies are required to investigate changes in plasma renin with obesity. However, the rate-limiting nature of AGT in plasma of lean and obese mice, coupled with obesity-induced reductions in PRC, suggests that circulating concentrations of Ang II were not derived from blood-borne AGT.
In this study, reduced adipose tissue renin-like activity and Ang II concentrations paralleled reductions in plasma Ang II concentrations and SBP in HF-fed adipocyte AGTdeficient mice. These results suggest that adipose tissue converts AGT to Ang II, which is then released into the systemic circulation. In support, similar to previous findings suggesting a complete RAS in adipose tissue (for review see), 39, 40 mouse adipose tissue expressed ACE, prorenin receptor, cathepsin D, and tonin mRNA. Expression levels of the prorenin receptor and ACE were modestly increased by HF feeding, suggesting that nutritional regulation of these adipose RAS components may have contributed to increased conversion of AGT to Ang II in adipose tissue. In addition, expression of several of these synthetic RAS components, as well as Ang II concentrations, were more abundant in adipose compared with liver. Conversion of AGT to angiotensin peptides through tonin or cathepsin may have contributed to increased angiotensin I release from adipose tissue explants. Alternatively, the adipocyte prorenin receptor may have interacted with circulating prorenin to increase production of angiotensins in adipose tissue of obese mice. Adipose tissue expands markedly with obesity; by comparison, the mass of liver or other Ang II-producing tissues (eg, kidney) did not increase appreciably with obesity. These results suggest that the expanded adipose mass with obesity becomes an important source of systemic Ang II in the control of blood pressure.
An important finding of this study was that obesity-induced increases in SBP were not observed in adipocyte AGT-deficient mice. The RAS is generally considered to be activated in obese rodents and humans (for review see Reference 41 ). Ang II activates the sympathetic nervous system 42, 43 and increases sodium retention, 2 mechanisms that have been consistently linked to obesity-associated hypertension. [2] [3] [4] Given the marked reductions in plasma Ang II concentrations in adipocyte AGT-deficient mice, it is likely that diminished Ang IImediated regulation of sodium reabsorption and sympathetic nervous system activity contributed to the pronounced effects of adipocyte AGT deficiency to prevent obesity-associated hypertension.
In conclusion, results demonstrate that adipocyte-derived Ang II is a primary contributor to obesity-induced elevations in plasma Ang II concentrations and SBP. Reductions in plasma Ang II concentrations were paralleled by decreased adipose tissue Ang II concentrations in HF-fed adipocyte AGT-deficient mice. Adipose tissue expressed relatively greater abundance of Ang II synthetic processing enzymes and Ang II concentrations than liver. These results demonstrate that adipose tissue is a significant contributor to an activated systemic RAS in the development of obesity-associated hypertension.
Perspectives
Evidence supports activation of the RAS in obesityrelated hypertension. Adipose tissue expresses several RAS components that may link obesity to hypertension. We demonstrate that adipocyte AGT deficiency prevents obesity-induced increases in plasma Ang II concentrations and SBP. Adipose tissue Ang II concentrations were markedly reduced in adipocyte AGT-deficient obese mice. Our results suggest that adipose-derived Ang II contributes to the systemic RAS and blood pressure control in obese Figure 6 data were analyzed by three-way ANOVA on log-transformed responses, with the modification that mouse-specific random effects were included. Statistical significance was declared at P<0.05. Figure S3 . SBP (12 hour averages for each mouse) of LF-fed Agt fl/fl and Agt aP2 mice during the night and light cycle. Carotid artery catheters and radiotelemeters were implanted at week 15 of LF, mice were allowed one week to recover, and SBP was recorded for 3 -5 days. Data are mean ± SEM from n = 6-7 mice/group (LF) over the 3 -5 days of recording. *, P<0.05 compared to night cycle within genotype. 
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